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We have analyzed the functions encoded by the bgl operon in-Escherichia coli K-12. Based on the ability of
cloned regions of the operon to complement a series of Bgl- point mutations, we show that the three bgl
structural genes, bglC, bglS, and bglB, are located downstream of the regulatory locus bglR in the order
indicated. Using a bgl-lacZ transcriptional fusion, we show that bglC and bglS are involved in regulating operon
expression. The presence of the bglC gene in trans is absolutely required for the expression of the fusion, which
is constitutive when only the bglC gene is present. When the bglC and the bglS genes are both present in the
ceil, expression of the fusion requires a f-glucoside inducer. From these observations, we conclude that (i) the
bglC gene encodes a positive regulatory of bgl operon expression and (ii) the bglS gene encodes a negative
regulator of operon expression, causing the requirement for a 0-glucoside inducer. These conclusions are
supported by our observations that (i) a majority of bglC mutants exhibits a Bgl- phenotype, whereas rare
trans-dominant mutations in bglC result in constitutive expression of the bgl operon and the fusion, and (ii)
mutations in the bgLS gene lead to constitutive expression of the fusion. Based on several lines of evidence
presentedi, we propose that the bglS gene product has an additional role as a component of the j8-glucoside
transport system.
The bgl operon in Escherichia coli K-12 specifies the
enzymes involved in the catabolism of aromatic 3-glucosides
such as arbutin and salicin. The operon is cryptic and
uninducible in wild-type strains, and therefore wild-type
cells are unable to utilize salicin or arbutin as a carbon
source. Several classes of mutations have been shown to
activate the cryptic operon. The major class of activating
mutations is effective in cis and has been characterized as
insertions of IS] or IS5 or point mutations that map within
the regulatory locus bglR (9). The insertion sequences and
point mutations have been shown to enhance transcription
from the unique bgl promoter, present in the bglR region,
which is active at a low level in wild-type cells (10).
Transcriptional activation, however, does not result in con-
stitutive expression of the operon. After activation, induc-
tion of the operon requires the presence of a P-glucoside
sugar. Expression of the operon is also subject to catabolite
repression.
In addition to the bglR site, three structural genes of the
bgl operon were reported earlier (7). The bglB gene was
shown to encode the enzyme phospho-i-glucosidase B,
which hydrolyzes phosphosalicin. The structural gene en-
coding the ,B-glucoside transport system I, the bgl-specific
component of the phosphoenol pyruvate-dependent phos-
photransferase system (2), was identified by measuring
phospho-p-glucosidase B activity in cell extracts from Bgl-
mutants. A trans-dominant mutation, which led to constitu-
tive bgl expression, suggested the presence of a third bgl
gene. Based on the unique phenotype of the constitutive
mutation, it was postulated that expression of phospho-3-
glucosidase B and the ,B-glucoside transport system is under
positive control. Initial mapping of the bgl genes suggested
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that the genes encoding the hydrolytic and transport func-
tions are located on either side of the bglR site, forming
divergent transcriptional units.
An unlinked locus termed bglA, which specifies a second
phospho-p-glucosidase, has been identified (8). This en-
zyme, termed phospho-,B-glucosidase A, preferentially
cleaves phosphoarbutin and is produced constitutively by
wild-type cells. However, wild-type cells are unable to
utilize arbutin due to lack of expression of the P-glucoside
transport system I of the bgl operon. Therefore, arbutin
utilization also requires an activated bgl operon for uptake
and phosphorylation of the substrate.
The results presented in this paper confirm the presence of
three structural genes in the bgl operon. We show that the
three genes bglC, bglS, and bglB are contained within a
5.7-kilobase (kb) region downstream from the transcription
start site in bglR characterized previously (10). This operon
structure, indicated by our observations, differs from the
structure proposed earlier (7). Based on studies with a
bgl-lacZ transcriptional fusion, we show that the first gene in
the bgl operon, bglC, encodes a positive regulator of bgl
operon expression. We also show that the second gene,
bglS, encodes a negative regulator of the bgl operon. How-
ever, loss of bglS gene function simultaneously results in a
Bgl- phenotype, suggesting that the bglS gene product also
has a direct role in P-glucoside utilization. We propose that
the bglS gene product, in addition to being a negative
regulatory of bgl operon expression, is the bgl-specific
component of the phosphoenolpyruvate-dependent phos-
photransferase system. Specific roles of the bglC and bglS
genes in the regulation of the operon are considered.
MATERIALS AND METHODS
Strains. The E. coli K-12 strains used in this study are
listed in Table 1. AE10 is a spontaneous Bgl+ derivative of
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TABLE 1. E. coli strains, bacteriophages, and plasmidsa
Strain, phage, or Genotype Source or
plasmid reference
E. coli
AE10 F- AiacX74 thi bglRl1 (bglR::ISJ)
(Bgl+)
AE304 As AE10 and tsx (T6)r (Bgl+)
AE304-1 As AE304 and tna::TnIO bglR
bglSl
AE304-2 As AE304 and tna::TnlO bglR
bglS2
AE304-3 As AE304 and tna::TnlO bglR
bglB3(Am)
AE304-4 As AE304 and tna::TnlO bglR
bglS3
AE304-6 As AE304 and tna::TnlO bglR
bglB6
AE304-7 As AE304 and tna::TnlO bglR
bglC7(Am)
AE304-9 As AE304 and tna::TnlO bglR
bglC8
AE304-10 As AE304 and tna::TnlO bglR
bglC1O
AE325 F- bglR trpB proC::TnS ilvO tna-5
(Bgl+)
JF50 F- Alac mel gyrA supF
JF201 F- AlacX74 A(bgl-pho)201 ara thi
gyrA
MA10 As AE10 and srl::TnlO recA56
(Bgl+)
MA46 As MA10 and bglR::ISI bglB::TnS
bglC4
MA46-200 As MA46 and X bglR7 bglC' lacZ+
lacY+ ((bgl-lac)
MA110 As AE10 tna and A(bgl-pho)
srl::TnJO recA56
MA152 As MA110 and X bglR7 bglC' lacZ+
lacYr (F(bgl-lac)
MA200 As MA10 and X bgiR7 bglC' lacZ+
lacsA (D(bgl-lac) (bgl2 )
MA200-1 As MA200 and bglS201
MA200-2 As MA200 and bglS202
MA200-3 As MA200 and bglS203
MA200-4 As MA200 and bglS204
MA200-33 As MA200 and bglC33 (Bglc)
MA221 As AE325 and tna+ recA56 lac
bgiC21
MA222 As AE325 and tna+ recA56 lac
bglC22
MA223 As AE325 and tna+ recA56 lac
bglB23(Ts)
MA225 As AE325 and tna+ recA56 lac
bglB25
MA226 As AE325 and tna+ recA56 lac
bglB26(Ts)
MA227 As AE325 and tna+ recA56 lac
bgiB27
MA229 As AE325 and tna+ recA56 lac
bglB29
MA231 As AE325 and tna+ recA56 lac
bglS31
MA233 As AE325 and tna+ recA56 lac
bglC23
MA234 As AE325 and tna recA56 lac
bglB34
SP3 F+ bglRl (bglR::ISI) bgiC4 lamB
(Bglc)
WP72 F- galE arg pro thi rpsL tna::TnJO
bglR (Bgl')
J. Felton
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TABLE 1-Continued
Strain, phage, or Genotype Source orplasmid reference
Bacteriophages
XNF1955 X cI857 X SamlO0 lacZ' lacY+ 14
XMN200 X c+ S+ bglR7 bglC' lacZ+ lacY+
F(bgl-lac)
Plasmids
pAR6 bglR° bglC+ bglS+ bglB+ (Bgl-) 10
glmS+ phoS+ phoTr phoU+ Apr
Tcr
pAR7 As pAR6 and bglR7 (bglR::IS5)
(Bgl+)
pAR8 As pAR7 A(glm-pho-IS5') (Bgl+)
pAR10 bglR7 bglC' Apr
pAR16 bglRl bglC4 bglS+ bglB+ Apr Tcr
(Bglc)
pAR18 bglR7 bglC+ bglS+ bglB'Apr
pMBO41 trpA'-lac'Z lac Y+ lacA' Apr 3
pMN5 bglC' bglS+ bglB' Apr
pMN25 bglR25 bglC+ bglS' Apr
pSAL6 bglR3 (bglR: :IS1) bglC+ bglS+
bglB+ Apr Tcr (Bgl+)
plH bglC' bglS+ bglB+
p6J bglS' bglB+
a Strains, bacteriophages, and plasmids for which no reference has been
cited were constructed as part of this work. Phenotypes of Bgl+ strains are
indicated in parentheses.
the laboratory strain RV. The activating mutation present in
AE10 was characterized as an IS] insertion in bgiR. AE304,
a derivative of strain AE10, was used as the parent strain for
transducing one class of bgl mutations from WP72 after
localized mutagenesis (described below). The mutations
were transduced by using a TnJO insertion in the tnaA gene.
The bgl operon can be cotransduced with tna at about 80%
efficiency. Strains MA221 through 234 were derivatives of
strain AE325 carrying a second set of bgl mutations
transduced from WP72 after mutagenesis as in the previous
case. The recA56 allele was introduced by using a TnJO
insertion in srl after transducing the tna::TnJO mutation to
tna+.
The strain JF201, which carries a deletion of the chromo-
somal bgl operon and the adjacent phoUT genes, was
described previously (10). The phoUT deletion results in the
constitutive synthesis of alkaline phosphatase encoded by
the phoA gene. The Phoc phenotype can be suppressed by
plasmids carrying the phoUT genes. Strain MA110 was
derived by transducing the 4(bgl-pho)201 mutation from
JF201 into AE10 with the tna::TnJO marker. Tetr transduc-
tants were screened for a Bgl- Phoc phenotype. The recA56
allele was introduced after selecting for Tets clones (1).
Strain MA46 was constructed by transducing the bglC4
allele from strain SP3 with a TnS insertion in bglB. The
presence of the bglC4 allele was confirmed by screening
Kanr transductants for an Arbc phenotype as described
below.
7 Plasmids. Construction of the plasmids pAR6 and pSAL6
has been described previously (10). Plasmid pAR7, a spon-
W. Peters taneous Bgl+ derivative of pAR6, contains an ISS insertionin bglR. Plasmids pAR10 and pAR18 were generated by
deleting sequences from pAR7 with Hindlll restriction sites.
The bglC+ plasmid pMN25 was constructed by subcloning
Continued the 0.5-kb HindIII-HpaI restriction fragment from pSAL6
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FIG. 1. Construction of a bgl-lacZ transcriptional fusion. Sym-
bols: 0, activating IS5 insertion in bglR; *, pBR322 sequences;M
sequences. Plasmid pMBO41 is a derivative of pMBO40 (3) in
which a 205-base-pair EcoRI restriction fragment carrying the
lacUVS promoter has been deleted.
downstream of the unique HindIlI site in plasmid pAW25
(10). This construction reconstitutes the bgl sequences from
the bglR site to the second HpaI site in the operon (see Fig.
3).
The plasmid plH was constructed by partial digestion of
pSAL6 DNA with HindIII and subsequent ligation. The
bglS+ plasmid pMN5 was derived by subcloning a 2.3-kb
HindIII-ClaI restriction fragment from pSAL6 into the
HindIII-ClaI site of pBR322. HpaI restriction sites in pSAL6
were used to delete bgl sequences to generate the bglB+
plasmid p6J. In these three constructions, the bgl sequences
are located downstream of a promoter in the tet gene of
pBR322 (15).
The plasmids pAR16 and pMN33, carrying the bglC4 and
bglC33 alleles, respectively, were derived by transferring the
bglC mutations from the chromosomes of the parent strains
to a bgl plasmid as described earlier (10). Hybrid plasmids
containing wild-type and mutant sequences, used in the
mapping of the two bglC alleles, were constructed as shown
in Fig. 4.
Media. Minimal and enriched media for routine use were
prepared from standard recipies (6). Media used for growing
strains carrying pBR322-derived plasmids contained 100 ,ug
of ampicillin per ml. MacConkey arbutin and salicin media
were prepared as described previously (11).
Localized mutagenesis of the bgl operon. The Bgl- mutants
employed in the genetic analysis of the bgl operon were
generated by localized mutagenesis of the bgl operon region.
The Bgl+ parent strain WP72, which carries a TnlO trans-
poson in the tnaA gene (80% cotransducible with bgo, was
mutagenized with nitrosoguanidine (6). Bacteriophage P1
was grown on the mutagenized strain, and the resulting
lysate was used to transform a Bgl+ strain to tetracycline
resistance. Tetr transductants were screened for the simul-
taneous acquisition of a bgl mutation. In this way we were
able to enrich for mutations in the bgl operon. Eighteen Bgl-
mutants isolated from 664 Tetr transductants were used for
further analysis. Mutations in the bglB gene were identified
by their characteristic Arb+ Sal- phenotype. Temperature-
sensitive and amber mutations were recognized by the
suppression of the Bgl- phenotype under permissive condi-
tions.
Molecular cloning. All manipulations with recombinant
DNA were carried out by standard procedures (5). Restric-
tion enzymes and other enzymes used in recombinant DNA
experiments were purchased commercially and were used
according to the specifications of the manufacturers.
Construction of a bgl-laeZ transcriptional fusion. The bgl-
lacZ transcriptional fusion used in these studies was con-
structed in vitro by fusing sequences containing an IS5-
activated bgl promoter and a portion of the bglC gene to
lacZ. This construction strategy is outlined in Fig. 1. A 12-kb
HindIII-BamHI fragment containing the bgl sequences and
the pBR322 vector, derived from plasmid pAR7, was iso-
lated and ligated with an 8-kb HindIII-BamHI fragment
containing the lacZYA genes derived from the plasmid
pMB041 (3). The ligated DNA was used to transform the
Bgl+ strain MA10. Ampr transformants were screened on
minimal succinate medium containing X-gal (5-bromo-4-
chloro-3-indolyl-f-D-galactopyranoside), the chromophoric
substrate for P-galactosidase, and 10 mM 3-methyl glucoside
as inducer. The presence of the correct fusion was verified
by restriction analysis of plasmid DNA isolated from trans-
formants that gave rise to blue colonies. The bgl-lacZ fusion
was transferred from the plasmid pMN200 to the X vector
NF1955 (11) by ligating EcoRI digests of the plasmid and X
NF1955 DNA. The ligated DNA was packaged in vitro with
X packaging extracts (11). Phages carrying the bgl-lacZ
fusion gave pale blue plaques on X-gal plates with a lawn of
an Su' host deleted for the chromosomal lac operon. The X
cI857 and the X SamlOO mutations, present in the original
isolates, were replaced with the respective wild-type alleles
by crossing the phage with wild-type X phage. The recombi-
nant phages were recognized by their ability to form turbid
blue plaques on X-gal plates at 37°C with an Su- host.
Measurements of 13-galactosidase activity. Assays for -
galactosidase activity were carried out as described previ-
ously (6). Cells were grown in minimal medium containing
0.4% succinate as the carbon source. Average values of units
of activity were computed based on at least four independent
measurements in each case.
Screening for constitutive expression of the bgl operon.
Constitutive expression of the bgl operon was detected by
using para-nitrophenyl-p-glucoside as a substrate (7).
Strains to be tested were grown on minimal succinate plates
at 37°C for 24 h. One drop of a 4 x 10-2 M solution of
p-nitrophenyl-p-glucoside was placed on the patches of cells
at room temperature. Strains that expressed the bgl operon
constitutively developed a bright yellow color in 60 s due to
J. BACTERIOL.
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FIG. 2. Mapping of the bglR site relative to the structural genes of the bgl operon. Symbols: O, activating IS5 insertion present in pAR7;
U, pBR322 sequences. Phenotypes of the resulting plasmids were tested in strain JF201 (Abgl-pho-201).
the cleavage of the phosphorylated substrate, which liber-
ated the chromophore p-nitrophenol.
RESULTS
Location of the bgl genes relative to the bglR site. The bglR
region contains the transcription start site and the target sites
for insertion sequences and point mutations that activate the
bgl operon (10). Earlier genetic analysis with three-factor
cotransductional crosses had suggested that the bglR site is
located between two bgl structural genes (7). Based on this
result, it was proposed that the bgl structural genes are
transcribed bidirectionally from bglR.
We determined the location of the bgl structural genes
with respect to the bglR site by subcloning DNA located on
either side of the bglR site. EcoRI restriction fragments from
the Bgl+ plasmid pAR7, which contains an EcoRI site in the
activating IS5 element in bglR, were subcloned in pBR322
and analyzed for bgl function (Fig. 2). One of the resulting
plasmids, pAR8, which contained 1.1 kb of the activating IS5
insertion and 5.7 kb ofDNA downstream of the bgl promoter
in bglR (10), conferred a Sal' Arb+ phenotype on strains
deleted for the chromosomal bgl operon. Expression of the
bgl operon in pAR8 was inducible by P-glucosides and
required cyclic AMP binding protein and cyclic AMP. The
6.9-kb EcoRI restriction fragment conferred an identical
phenotype when present in single copy in the chromosome
as part of a A prophage. These results indicate that the bgl
structural genes are contained within the 5.7-kb region
downstream of the bglR site.
Mapping of bgl mutations. To analyze the functions en-
coded by the bgl operon, we isolated a series of Bgl-
mutants by using localized mutagenesis as described in
Materials and Methods. The locations of 18 bgl mutations
were determined by complementation analysis with a series
of plasmids containing different portions of the bgl operon
(Fig. 3). Plasmids pAR10, pAR18, and pMN25 were derived
from Bgl+ plasmids and contain an activated bgl promoter.
Plasmids plH, pMN5, and p6J are deleted for the bglR site
but still express the cloned bgl genes, presumably from a
promoter within the tet gene of the pBR322 vector (15).
Transformants of the various Bgl- mutants carrying these
deletion plasmids were screened on MacConkey salicin
plates for complementation. Positive complementation was
indicated by the formation of bright red colonies. The results
of these studies (Table 2) indicate that the bgl mutations fall
into three groups based on complementation by specific bgl
plasmids. The properties of each group of Bgl- mutants are
described below.
The bgl mutations in strains AE304-7, -9, and -10 and
MA221, 222, and 233 were complemented strongly by plas-
mid pMN25 (complementation of AE304-10 and MA222 was
weaker compared with the others). Plasmid pAR10, which
carries DNA up to the first HindIII site in the operon, gave
only partial complementation of these mutants as indicated
by the formation of pale pink colonies on MacConkey salicin
plates. These results indicate that a gene, which we have
designated bglC, extends beyond the first HindIII site but
does not extend beyond the second HpaI site downstream of
the bgl promoter (Fig. 3). The partial complementation
observed with pAR10 is likely to be due to a low level of
activity of the truncated bglC gene product, when expressed
from a multicopy plasmid.
The bgl mutations in strains AE304-1, -2, and -4 and
MA231 were complemented strongly by plasmid plH, but
not by p6J. Therefore, these mutations define a gene, which
we designate bglS, that starts within the region downstream
of the first HindIlI site and upstream of the second HpaI
site.
A third set of bgl mutations, present in strains AE304-3
and -6 and MA223, 225, 226, 227, 229, and 234, were
complemented by both plH and p6J but not by pAR18 or
pMN25. These strains are characterized by an Arb+ Sal-
phenotype. Hence, these mutations define the bglB gene, the
VOL. 169, 1987
2574 MAHADEVAN ET AL.
i pAR18
i I pMN25
i \>r pAR10
r I-b pho
EcoRl Hindill ClO I
i i
HindIm
Hpo I HpaI
ECORI
'1 %
pMN5
plH
fl ~~~~~p6J
FIG. 3. Structural organization of the bgl operon. Chromosomal DNA is represented as a solid line in the center. Plasmids used in the
complementation analysis of the Bgl- mutants are indicated above and below the chromosomal DNA. For simplicity, vector sequences have
been omitted. Symbols: O, activating IS5 insertion in bgIR; 0, point mutation in bglR; l, transcription from the bgl promoter; #, transcription
from the pBR322 vector.
structural gene encoding the enzyme phospho-p-glucosidase
B, which preferentially cleaves phosphosalicin (7). Strains
with bglB mutations can utilize arbutin, by using the un-
linked locus bglA (8), and the P-glucoside transport system I,
specified by the bgl operon (7). Plasmid pAR18, which
carries bgl DNA up to the second HindIII site in the operon
(Fig. 3), confers an Arb+ Sal- phenotype to cells deleted for
the chromosomal bgl operon, indicating that this HindIII site
lies within the bglB gene.
Plasmid pMN5, which carries DNA from the first HindIlI
site to the ClaI site (Fig. 3), complemented the bglS muta-
tions described above, resulting in an Arb+ phenotype.
However, these transformants had a Sal- phenotype, sug-
gesting that the bglS mutations tested were polar on the bglB
gene. The same results were obtained when these bglS
mutants contained pAR18 (Table 2). The complementation
to Arb+ by pMN5 indicates that the bglS gene is contained
within the 2.3-kb HindIII-ClaI fragment.
The analyses described above indicate the presence of
three bgl structural genes located downstream of bglR in the
order bglC bglS bglB.
Identification of the regulatory genes. Analysis of bgl
operon regulation was carried out by using a bgl-lacZ
transcriptional fusion constructed as described in Materials
and Methods. The fusion, present in single copy on a A
prophage, contained the bgl promoter including the activat-
ing IS5 mutation and a portion of the bglC gene. Regulation
of expression of the fusion was studied by measuring I-
galactosidase activity in strains with different bgl genotypes
(Table 3). In strain MA152, which is deleted for the chromo-
somal bgl operon, little expression from the bgl-lacZ fusion
was detected by colony color on MacConkey lactose plates
or by P-galactosidase assays. However, constitutive expres-
sion of the fusion was observed when plasmid pMN25,
carrying the complete bglC gene, was present in the cell.
Plasmid pMN5, which expresses only the bglS gene, had no
effect on the expression of the fusion. In the presence of
plasmid pAR18 (bglC+ bglS+) or plasmid pSAL6 (bglC+
bglS+ bglB+), the expression of the fusion was inducible by
p-glucosides. The same result was observed in the Bgl+
strain MA200. These observations indicate that the bglC
gene product is absolutely required for the expression of the
bgl-lacZ fusion and, in the absence of the bglS gene, leads to
constitutive expression of the fusion. Therefore, bglC spec-
ifies a positive regulator of expression of the bgl-lacZ fusion.
When the bglC and bglS genes are simultaneously present,
expression of the bgl-lacZ fusion requires a P-glucoside
inducer, indicating a negative role for the bglS gene product
in regulating bgl expression.
Mutations leading to constitutive expression of the bgl-lacZ
fusion. Regulation of bgl operon expression was further
characterized by selecting for mutations that result in con-
TABLE 2. Complementation analysis of Bgl- mutants'
Complementation with plasmids:
Strain
pAR10 pMN25 pAR18 plH p6J
AE304-1 - - - + -
AE304-2 - - - + -
AE304-3 - - - + +
AE304-4 - - - +
AE304-6 - - - + +
AE304-7 + + + - -
AE304-9 + + + - -
AE304-10 - + + - -
MA221 + + + - -
MA222 - + + - -
MA223 - - - + +
MA225 - - - + +
MA226 - - + +
MA227 - - - + +
MA229 - - - + +
MA231 - - - + -
MA233 + + + - -
MA234 - - - + +
a Complementation was indicated by colony color on MacConkey salicin
plates: (+) strong complementation (bright red colonies), (±) partial comple-
mentation (pale pink colonies), (-) no complementation (white colonies).
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TABLE 3. Expression of a bgl-lacZ transcriptional fusion in various strain backgrounds
Phenotype on MacConkey-lactose P-Galactosidase activity (U)
Strain Plasmid mediuma
-Inducer +Inducerb -Inducer +Inducerc
MA110 (control) None - - <1 <1
MA152 (AbgI) None - - 4 3
MA152 pMN25 (bglC+) + + 54 58
MA152 pMN5 (bglS+) - - NDd ND
MA152 p6J (bgIB+) - - ND ND
MA152 pAR18 (bglC+ bglS+) - + ND ND
MA152 pSAL6 (Bgl+) - + 4 48
MA200 (Bgl+) None - + 3 43
a Expression of the bgl-lacZ fusion was partly determined by colony color on MacConkey lactose plates: (+) pink colonies, (-) white colonies.
b
-Methylglucoside (10 mM) was used as the inducer.
c Salicin (7 mM) was used as the inducer.
d ND, Not determined.
stitutive expression of the bgl-lacZ fusion. Strain MA200, a and simultaneous loss of bgl expression are linked to the
Bgl+ strain lysogenic for the X phage carrying the transcrip- chromosomal bgl operon.
tional fusion, was used to isolate mutants that express the Mutations in MA200-1 through -4 were mapped more
fusion constitutively. Spontaneous Lac+ mutants were iso- precisely by complementation analysis with the deletion
lated by their ability to grow on minimal lactose medium in plasmids described above (Table 4). Plasmids pMN25 and
the absence of a ,B-glucoside inducer. The major class of p6J, expressing the bglC and bglB genes, respectively, had
spontaneous Lac+ derivatives (83 of 84) had a Lacc Bgl- no effect on the strains. However, transformants of the
phenotype. Four representative strains from this class, mutant strains carrying plasmid plH, which expresses the
MA200-1 through -4, were chosen for detailed analysis. A bglS and bglB genes, showed an Arb+ Sal+ phenotype. The
single Lacc isolate, MA200-33, showed constitutive expres- presence of an intact bglS gene also resulted in inducible
sion of the bgl operon (see below). expression of the bgl-lacZ fusion. These results indicate that
The observation that the Lacc mutations present in strains the mutations in strains MA200-1 through -4, which lead to
MA200-1, through -4 had simultaneously acquired a Bgl- constitutive expression of the bgl-lacZ fusion and simulta-
phenotype suggested that the mutations were likely to map neously result in a Bgl- phenotype, are recessive and are
within the chromosomal bgl operon. To determine whether complemented by a plasmid expressing the bglS gene.
the mutations were linked to the chromosomal bgl operon, Hence, we conclude that these mutations map within the
rec+ derivatives of the mutant strains were transduced with bglS gene. This is consistent with our observation that a
P1 phages grown on a Bgl+ strain carrying a TnWO insertion derivative of strain MA231 (bglS), which carries the bgl-lacZ
in tna linked to the bgl operon. Tetr transductants were fusion, shows constitutive expression of the fusion. The
screened for Bgl and Lac phenotypes. About 80% of the Tetr presence of a plasmid expressing the wild-type bglS gene in
transductants showed a Bgl+ phenotype. Transduction to this strain also results in inducible expression of the fusion.
Bgl+ simultaneously resulted in inducible expression of the These results indicate once again a negative role for the bglS
bgl-lacZ fusion, similar to the original strain MA200. In gene product in regulating the expression of the bgl-lacZ
addition, X phages carrying the bgl-lacZ fusion were isolated fusion.
from the four Lacc mutants and used to relysogenize the Plasmid pMN5, which expresses only the bglS gene,
Bgl+ strain MA10. These lysogens showed inducible expres- complemented the mutations described above, resulting in
sion of the bgl-lacZ fusion, similar to the original lysogen an Arb+ phenotype. However, these strains remained Sal-,
MA200, indicating that the X prophages carrying the fusion, suggesting that the mutations in strains MA200-1 through -4,
present in MA200-1 through -4, are unaltered. Therefore, the are also polar on the bglB gene, similar to the independently
mutations leading to constitutive expression of the fusion isolated bglS mutants described earlier (Table 2).
TABLE 4. Properties of mutants which show constitutive expression of the bgl-lacZ fusiona
Phenotype on MacConkey medium plus: ,B-Galactosidase activity (U)
Strain Plasmid Lactosec
Salicinb -Inducer+Induc r-
-Inducer +Inducer'
MA200 (Bgl+) None + - + 3 43
MA200-1 None - + + 194 176
MA200-1 pMN25 (bglC+) - + + NDf ND
MA200-1 p6J (bglB+) - + + ND ND
MA200-1 plH (bglS+ bglB+) + - + ND ND
MA200-1 pMN5 (bglS+) [-] - + 3 41
a Data for one of the four Lac' mutants characterized is shown. Three other mutants tested showed similar complementation pattern and ,3-galactosidase levels.
b Representation ofphenotype on MacConkey salicin plates is as in Table 2. Complementation that resulted in a Sal phenotype on MacConkey salicin plate but
an Arb+ phenotype on MacConkey arbutin plates is indicated as [-1.
I Phenotypes on MacConkey lactose plates are represented as in Table 3.
d Salicin (7 mM) was used as the inducer.
I
-Methylglucoside (10 mM) was used as the inducer.
f ND, Not determined.
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The levels of expression of the bgl-laci
mutants are higher compared to the induc
pression in Bgl+ strains (Table 4). This diffe
be related to catabolite repression caused b:
of glucose 6-phosphate from salicin (the indi
strain. Since the bglS mutants show a Bgl-
are unable to utilize the inducer as a substra
repression is likely to occur in these strains
Mutations leading to constitutive bgl exp
original studies on bgl operon expressi(
Schaefler described a single mutation that re
tutive expression of the bgl operon (7).
indicated that the mutation was located neai
With merodiploid analysis, the mutant allel
be dominant in trans over the wild type.
observation, Prasad and Schaefler propose
tion defines a gene which encodes a positive
operon expression.
We analyzed the mutation described
Schaefler after transferring it from the origii
a bgl plasmid by P1 transduction. The Bg
tained, pAR16 and pAR17, were found to be
bgl expression, indicating that the mutation
successfully transferred to the plasmids. T(
tion, a series of hybrid plasmids was constn
specific DNA fragments from plasmids pA
pSAL6 (Bgl+). The properties of recombinai
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FIG. 4. Mapping of mutations leading to const
of the bgl operon. Symbols: E, activating IS] inse
sequences; , DNA from plasmid pSAL6 (
from plasmid pAR16 (bglC4); -, DNA from
(bglC33). The PpuMI-BamHI restriction fragme
bglR region present in plasmids pMN6PI and pM1
from plasmid pMN25. The activating mutation pr
cases is a point mutation in bglR indicated (0
indicated was observed in a Abgl strain. Constituti
detected as described in Materials and Methods.
Z fusion in bglS
-ed levels of ex-
rence is likely to
y the production
ucer) in the Bgl1
- phenotype and
te, no catabolite
tression. In their
Dn, Prasad and
-sulted in consti-
Initial mapping
r the bglB locus.
le was shown to
. Based on this
d that the muta-
regulator of bgl
by Prasad and
TABLE 5. Effects of multiple copies of bglC and bglS genes on
regulation
Strain Plasmid 13-Galactosidase activity (U)
-Inducer +Inducer'
MA200 (Bg1) pBR322 3 40
MA200 pMN25 (bglC+) 5 47
MA200 pMN5 (bglS+) 3 15
MA200 pSAL6 (Bgl+) 4 49
MA46-200 (bglC4) pBR322 46 110
MA46-200 pMN25 (bglC+) 39 227
MA46-200 pMN5 (bglS+) 10 16
MA200-33 (bglC33) pBR322 160 57
MA200-33 pMN25 (bglC+) 64 33
MA200-33 pMN5 (bglS+) 123 33
a Salicin (7 mM) was used as the inducer.
nal strain SP3 to 4) indicated that the mutation present in strain SP3, which
>1+ plasmids ob- confers constitutive expression of the bgl operon, lies in the
constitutive for 0.2-kb region (between the HindIII and HpaI sites) within
in SP3 had been the gene that we have designated bgIC. This is consistent
D map the muta- with our observation that the bglC gene encodes a positive
ucted by ligating regulator of bgl operon expression. We have designated the
kR16 (Bglc) and bglC allele, present in strain SP3, bglC4.
nt plasmids (Fig. A second mutation exhibiting constitutive bgl expression,
present in strain MA200-33, was obtained by screening the
spontaneous Lac+ constitutive mutants of MA200 described~~ '*~'* in the previous section. Among the 84 Lacc derivatives
screened, one (MA200-33) showed constitutive bgl expres-
pSLL i*od".e sion. Strain MA200-33 showed constitutive bgl expression
even when it contained the Bgl+ plasmid pSAL6, indicating
pARIG a that the mutation in strain MA200-33 is dominant. When P1
phages grown on a Bgl+ strain carrying a TnJO insertion in
pMN33 consttutv tna were used to transduce a recA+ derivative of MA200-33,
80% of the Tetr transductants showed inducible bgl expres-
pIHNI comtitutlwv sion. This result indicated that the mutation in strain
MA200-33 is linked to the chromosomal bgl operon.
pIN= coUutive To localize the mutation in strain MA200-33 more pre-
cisely, the mutation was transferred to a plasmid by P1
transduction as in the previous case. The resulting plasmid,
PM"3sl - pMN33, gave constitutive expression of the bgl operon. The
properties of hybrid plasmids, constructed with DNA frag-
ments from pMN33 and pSAL6 (Fig. 4), indicated that the
pMN"E Inducltl- mutation in strain MA200-33, which leads to constitutive
expression of the bgl operon and the bgl-lacZ fusion, ispMN1ME Coitutive located within the 0.4-kb region upstream of the HpaI
restriction site in bglC, i.e., within the bglC structural gene.pMNS33E inducible This location of the bglC33 allele indicates that it is distinct
from the bglC4 allele.
pMNSI lniucible Effect of increased dosage of the bglC and bglS genes on
regulation. To understand the mode of action of the regulatory
pMN3PI constitutWv genes, the effect ofbglC and bglS in high copy on bgl regulation
was studied in strains containing the bgl-lacZ fusion and a
single copy of the chromosomal bgl operon (Table 5). The
bglC+ plasmid pMN25 had no effect on the expression of the
titutive expression bgl-lacZ fusion in the Bgl+ strain MA200, which carries a single
rtions; *, pBR322 copy of the bglC and bglS genes on the chromosome. How-(bglC ); , DNA ever, when the bglS+ plasmid pMN5 was present in strain
i plasmid pMN33 MA200, the induced level of 3-galactosidase was reduced overInt containing the twofold. In the presence of the Bgl+ plasmid pSAL6 (bglC+
esent in these two bglS+), the expression of the bgl-lacZ fusion in MA200 was). The phenotype unaltered. Thus, the presence of multiple copies of the bglS
ive expression was gene in trans to a single copy of the bglC gene has a negative
effect on the expression of the bgl-lacZ fusion.
I I 6--C=I----4 mmmm.d
I I
ff.t!p"m
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The effect of higher copy numbers of bglC and bglS on the
expression of the bgl-lacZ fusion was studied with single
copies of the bglC4 and bglC33 alleles on the chromosome.
Strains MA46-200 (bglC4) and MA200-33 (bglC33) showed
partially constitutive expression of the bgl-lacZ fusion in the
presence of the bglC+ plasmid pMN25, indicating the trans-
dominant phenotype of the two bglC alleles. The bglS+
plasmid, pMN5, caused a 75% reduction in the uninduced
levels of expression of the bgl-lacZ fusion in strain
MA46-200. Thus, the presence of a multicopy plasmid ex-
pressing bglS suppressed the constitutive phenotype of the
bglC4 allele. However, in contrast to the result obtained
with the bglC4 allele, the presence of the bglC33 allele led to
constitutive expression of the bgl-lacZ fusion even when
plasmid pMN5 (bglS+) was present. Over 75% of the original
uninduced level of ,B-galactosidase activity of MA200-33
could be detected in the presence of pMN5. Multiple copies
of the bglS gene are unable to effectively suppress the
constitutive phenotype of the bglC33 allele. This result
suggests that the opposing effects exerted by the bglS and
the bglC gene products are not independent.
DISCUSSION
Organization of the bgl genes. We have shown that the bgl
structural genes,which are required for regulated bgl expres-
sion, are encoded by the 5.7 kb ofDNA located downstream
of the bglR site. Since the bglR site has been shown to
contain the promoter elements involved in bgl expression
(10), our results indicate that the bgl structural genes must be
transcribed unidirectionally from bglR rather than
bidirectionally as proposed earlier (7). This is also confirmed
by the nucleotide sequence analysis of the phoSTU genes
immediately upstream of bglR (16). The phoU open reading
frame has been shown to end just upstream of the target
region for the insertion sequences in bglR. Therefore, it is
not likely that the region upstream of bglR encodes a bgl
structural gene. Hence, we conclude that the bgl structural
genes are contained within the 5.7-kb region downstream of
the bglR site and are transcribed unidirectionally from bglR,
constituting an operon.
The results of our analysis of the various Bgl- mutants
have indicated that there are at least three structural genes in
the operon. We have designated the first structural gene of
the operon bglC and the second gene bglS. The bglB gene
encoding the enzyme phospho-,-glucosidase B, which
mapped downstream of bglS, constitutes the third structural
gene of the operon.
Rak and co-workers have determined the nucleotide se-
quence of the bgl operon, and their results were communi-
cated to us while the manuscript of this paper was in
preparation. Their analysis has confirmed the presence of
three open reading frames bounded by the same restriction
sites defined by our genetic analysis. The conclusions based
on the nucleotide sequence analysis of the operon are
presented in the accompanying paper by Schnetz et al. (12).
Role of bglC and bglS in the regulation of the bgl operon.
Our studies with a bgl-lacZ transcriptional fusion have
shown that the presence of bglC in trans is necessary and
sufficient for the expression of the fusion in strains deleted
for the chromosomal bgl operon. Since the expression of the
fusion does not require a P-glucoside inducer in this case, it
is unlikely that the requirement for the bglC gene product is
related to an indirect process, such as uptake of ,B-
glucosides. We have also shown that loss of bglC function
due to mutations results in a Bgl- phenotype, whereas rare
mutations in bglC result in constitutive expression of the
operon. Hence, we conclude that the bglC gene specifies a
positive regulator of bgl operon expression.
The studies with the bgl-lacZ transcriptional fusion have
also shown that the bglS gene product is a negative regulator
of bgl operon expression. In the presence of bglS and bglC,
the expression of the fusion requires a ,B-glucoside inducer.
Mutations that inactivate the bglS gene result in constitutive
expression of the fusion. The single copy of the chromo-
somal bglC gene, in this case, stimulates the expression of
the bgl-lacZ fusion in the absence of a ,B-glucoside inducer
(Table 4). Therefore, induction of the operon is not likely to
occur through the direct activation of the bglC gene product
by the inducer. We propose that 3-glucosides induce the bgl
operon by relieving the negative effect exerted by the bglS
gene product.
The dual regulation of the bgl operon leads to two possible
schemes for the operation of the regulatory components.
The bglC and bglS gene products could exert their opposing
effects either independently or concurrently at the same
level of transcriptional regulation. The phenotype of the two
bglC mutations (bglC4 and bglC33) that lead to constitutive
expression of the bgl operon indicates that a mutation in the
bglC gene, in a single step, can overcome the negative effect
of the bglS gene product. Therefore, it is more likely that the
bglC and bglS gene products act at the same level of
regulation, either by competing for a common regulatory site
or by directly interacting with each other. The bglC4 and
bglC33 alleles are not likely to be mutations that increase the
steady-state level of the bglC gene product, since increasing
the copy number of the wild-type bglC gene in a cell carrying
a single copy of the bglS gene has no appreciable effect on
the expression of the bgl-lacZ fusion (Table 5). In addition,
the presence of the wild-type bglS gene in multiple copies
does not seem to have an appreciable effect on the pheno-
type of the bglC33 allele, as indicated by the measurements
of the expression of the bgl-lacZ fusion. The phenotype of
the bglC4 allele, however, has been shown to be suppressed
under the same conditions. Hence, it is most likely that the
bglS gene product exerts its negative effect by directly
interfering with the efficient functioning of the bglC gene
product. The bglC4 and bglC33 mutations are apparently
overcoming the inhibition by bglS, the bglC4 allele being
weaker than bglC33 in this respect. We hypothesize that
induction of the bgl operon by P-glucosides occurs as a
result of a structural alteration of the bglS gene product in
the presence of the inducer, which preempts its inhibitory
effect on the bglC gene product.
Role of bglS in j-glucoside utilization. All of the bglS
mutants characterized in this study exhibit a Bgl- pheno-
type. The presence of the plasmid pMN5, expressing the
bglS gene, did not restore the Sal' phenotype in these
strains, indicating that the bglS mutants are polar on the
bglB gene. The bglS mutants retained their Sal- phenotype
even in the presence of plasmid p6J expressing the bglB
gene. Since this strain is still incapable of salicin utilization
despite the expression of phospho-p-glucosidase B, the bglS
gene product must be required in some capacity other than
as a negative regulator. The presence of the plasmid pMN5
could restore the Arb+ phenotype in these mutants, indicat-
ing that the bglS gene product could facilitate utilization of
arbutin. Based on these observations, we propose that the
bglS gene product is the bgl-specific component of the
phosphotransferase system that is required for the uptake of
P-glucosides.
Does the bglC gene product play a direct role in 1B-
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glucoside utilization other than as a positive regulator of bgl
operon expression? The observation that plasmid plH,
expressing the bglS and bglB genes from a vector promoter,
still exhibits an Arb- Sal- phenotype in bglC mutants (Table
2) suggested that the bglC gene product may also be involved
in the uptake of P-glucosides. However, plasmid derivatives
that carry deletions of the bglC gene, extending toward the
bglS gene, conferred an Arb+ Sal' phenotype in the absence
of a functional bglC gene. This result suggests that there may
be bglC-dependent regulatory sites located on plasmid plH
and that deletion of these sites abolishes the requirement of
the bglC gene product as a positive regulator. Therefore, it is
not likely that the bglC gene product is directly involved in
,-glucoside utilization other than as a positive regulator of
bgl operon expression. Thus the bglS and bglB genes alone
specify the functions necessary for the utilization of P-
glucosides.
The bgl operon is rather unique in specifying a transport
protein which also functions as a regulator of gene expres-
sion. Studies on the put operon of S. typhimurium, involved
in the catabolism of proline, have indicated that the putA
gene product is both a negative regulator of put operon
expression and a membrane-bound bifunctional oxidase-
dehydrogenase (4). The glnA gene product of B. subtilis,
which constitutes the enzyme glutamine synthetase, has
been implicated in the autoregulation of the glnA gene (13).
Hence the presence of regulatory components with multiple
functions may be a more common feature among
procaryotes than currently understood.
Mode of action of the bglC gene product. Several possible
schemes can be postulated for the role of the bglC gene
product in transcriptional control. The three basic possibil-
ities are that the bglC gene product functions at the level of
(i) transcription initiation, (ii) stabilization of the bgl tran-
script, or (iii) antitermination at a specific site downstream of
the bgl promoter. We have several lines of evidence which
indicate that the bglC gene product mediates positive regu-
lation of the bgl operon at the level of antitermination of
transcription at a specific rho-independent terminator,
downstream of the transcription start site. These results will
be reported elsewhere.
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